Leaders In The Development of Next Generation Psychoactive Pharmaceuticals

PsyBio retains the global exclusive rights to a platform technology enabling highly efficient drug discovery, development, and production for pharmaceutical candidates through synthetic biology and metabolic engineering.

band _edited.png

TSXV : PSYB

Artboard – 9_2x.png

Jan 1, 2000

.00

 High

 Low

 Open

.00

.00

.00

 Volume

1,000,000

Current

+0.000 (0.00%)

OTC-QB : PSYBF

Artboard – 11_2x.png

Jan 1, 2000

.00

Current

+0.000 (0.00%)

 High

 Low

 Open

 Volume

.00

.00

.00

1,000,000

Group 792.png
Group 788.png

Why PsyBio Will be the Leader in the Psychedelic Drug Discovery Industry

Progress for Top 

40 Individual 

Molecules

Group 789.png

Current Pipeline:

88 Individual 

Molecules

Group 790.png

Fully Capitalized: 

Triple Subscribed Institutional 

Round

Group 791.png

IND and Clinical Trials: Pre-IND Submission in 2021 & Clinical Trials in 2022

Group 792.png

Intellectual Property: 

Blanket Submissions in Combinatorial Bacterial and Hybrid Synthesis

Brain.png

Psybio Media

Press

news 1.1.png

Be Up To Date With Our Latest Press Releases And The Future Of Psybio's Progress.

Videos

Movie.png

Learn More About Psybio's Progress, The People Behind It, And It's Evolution To Addressing Mental Health.

Podcast

micro .png

Listen To Our World Class Management Team Discuss The Latest Topics In Mental Well Being.